98%
921
2 minutes
20
N4BP1 (NEDD4-binding partner 1) is a key checkpoint for proper inflammatory responses; however, its cellular localization, biologic nature, and functions in other cellular processes remain largely unknown. In this study, we demonstrate that N4BP1 is a nucleocytoplasmic shuttling protein. Treatment with leptomycin B induces nuclear accumulation of N4BP1, and the region responsible for its nuclear distribution maps to amino acids 151 to 338. Further analysis identified a nuclear localization signal (NLS) spanning residues 279 to 299. Deletion or mutation of this NLS abolishes N4BP1 nuclear import, while fusing the NLS to GFP is sufficient to drive GFP into the nucleus. Notably, we found that N4BP1 forms protein aggregates in both the cytoplasm and nucleus. These aggregates lack ubiquitin-modified proteins but instead colocalize with NEDD8-modified proteins. Consistently, N4BP1 aggregates contain cullin-1 and cullin-2. The CoCUN domain is essential for recognizing neddylated proteins and mediating N4BP1 aggregate formation. N4BP1 aggregates exhibit liquid-liquid phase separation, as evidenced by their sensitivity to 1,6-hexanediol (an liquid-liquid phase separation inhibitor). Smaller N4BP1 aggregates can fuse into larger one and reassemble after 1,6-hexanediol-induced disruption. Furthermore, heat shock promotes N4BP1 aggregation, which confers cellular protection under stress conditions. Taken together, our findings reveal that N4BP1 is a nucleocytoplasmic shuttling protein. N4BP1 forms protein aggregates that contain neddylated proteins such as cullin-1 and cullin-2. This study uncovers the previously unrecognized role of N4BP1 in organizing neddylated protein aggregates and highlights its functional significance in stress adaption.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12365338 | PMC |
http://dx.doi.org/10.1016/j.jbc.2025.110511 | DOI Listing |
J Biol Chem
July 2025
Department of Pathogenic Biology, School of Medicine, Nantong University, Nantong China; Laboratory of Medical Science, School of Medicine, Nantong University, Nantong, China. Electronic address:
N4BP1 (NEDD4-binding partner 1) is a key checkpoint for proper inflammatory responses; however, its cellular localization, biologic nature, and functions in other cellular processes remain largely unknown. In this study, we demonstrate that N4BP1 is a nucleocytoplasmic shuttling protein. Treatment with leptomycin B induces nuclear accumulation of N4BP1, and the region responsible for its nuclear distribution maps to amino acids 151 to 338.
View Article and Find Full Text PDFCytokine Growth Factor Rev
June 2025
Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University &Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250013, China; Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University &
NEDD4-binding protein 1 (N4BP1) is emerging as a critical regulator of inflammation and immune responses, particularly through its effects on the nuclear factor-κ-gene binding (NF-κB) signaling pathway. This review summarizes the regulatory mechanisms by which N4BP1 inhibits NF-κB activation and its subsequent impact on inflammatory diseases, specifically psoriasis. We discuss its interaction with various components of the NF-κB pathway, revealing that N4BP1 serves as a negative regulator of NF-κB-related gene expression under both stimulated and unstimulated conditions.
View Article and Find Full Text PDFCancer Drug Resist
March 2025
Department of General Medicine, The 3rd Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Doxorubicin, pivotal for acute myeloid leukemia (AML) treatment, often succumbs to resistance, impeding therapeutic success. Although exosomal transfer is linked to chemoresistance, the detailed role of exosomal miRNAs in doxorubicin resistance remains incompletely understood. We employed miRNA sequencing to delineate the profile of exosomal miRNAs in doxorubicin-resistant K562/DOX cells and AML patients.
View Article and Find Full Text PDFScience
April 2025
Center for RNA Research, Institute for Basic Science, Seoul, Korea.
Exogenous messenger RNAs (mRNAs) require cellular machinery for delivery and translation but also encounter inhibitory factors. To investigate their regulation, we performed genome-wide CRISPR screens with in vitro-transcribed mRNAs in lipid nanoparticles (LNPs). Heparan sulfate proteoglycans (HSPGs) and vacuolar adenosine triphosphatase (V-ATPase) were identified as mediators of LNP uptake and endosomal escape, respectively.
View Article and Find Full Text PDFJ Gen Virol
March 2025
Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan.
Chronic infection with hepatitis B virus (HBV) (chronic HBV infection) places patients at increased risk for liver cirrhosis and hepatocellular carcinoma. Although nucleos(t)ide analogues are mainly used for the treatment of HBV, they require long-term administration and may lead to the emergence of drug-resistant mutants. Therefore, to identify targets for the development of novel anti-HBV drugs, we screened for HBV-suppressive host factors using a plasmid expression library of RNA-binding proteins (RBPs).
View Article and Find Full Text PDF